These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. A local bone anabolic effect of rhFGF2-impregnated gelatin hydrogel by promoting cell proliferation and coordinating osteoblastic differentiation. Kodama N, Nagata M, Tabata Y, Ozeki M, Ninomiya T, Takagi R. Bone; 2009 Apr; 44(4):699-707. PubMed ID: 19166987 [Abstract] [Full Text] [Related]
29. A theoretical model for simulating effect of parathyroid hormone on bone metabolism at cellular level. Wang Y, Qin QH, Kalyanasundaram S. Mol Cell Biomech; 2009 Jun; 6(2):101-12. PubMed ID: 19496258 [Abstract] [Full Text] [Related]
30. HIV-1 triggers apoptosis in primary osteoblasts and HOBIT cells through TNFalpha activation. Gibellini D, De Crignis E, Ponti C, Cimatti L, Borderi M, Tschon M, Giardino R, Re MC. J Med Virol; 2008 Sep; 80(9):1507-14. PubMed ID: 18649336 [Abstract] [Full Text] [Related]
31. Differential mRNA expression profiles in proximal tibia of aged rats in response to ovariectomy and low-Ca diet. Zhang Y, Dong XL, Leung PC, Wong MS. Bone; 2009 Jan; 44(1):46-52. PubMed ID: 18848653 [Abstract] [Full Text] [Related]
32. Regulation of osteoblast differentiation by slit2 in osteoblastic cells. Sun H, Dai K, Tang T, Zhang X. Cells Tissues Organs; 2009 Jan; 190(2):69-80. PubMed ID: 19033678 [Abstract] [Full Text] [Related]
33. Modifying RANKL/OPG mRNA expression in differentiating and growing human primary osteoblasts. Giner M, Montoya MJ, Vázquez MA, Rios MJ, Moruno R, Miranda MJ, Pérez-Cano R. Horm Metab Res; 2008 Dec; 40(12):869-74. PubMed ID: 18932123 [Abstract] [Full Text] [Related]
34. Effects of estradiol and progestogens on tumor-necrosis factor-alpha-induced changes of biochemical markers for breast cancer growth and metastasis. Seeger H, Wallwiener D, Mueck AO. Gynecol Endocrinol; 2008 Oct; 24(10):576-9. PubMed ID: 19012101 [Abstract] [Full Text] [Related]
36. Parathyroid hormone-related protein (107-139) increases human osteoblastic cell survival by activation of vascular endothelial growth factor receptor-2. Alonso V, de Gortázar AR, Ardura JA, Andrade-Zapata I, Alvarez-Arroyo MV, Esbrit P. J Cell Physiol; 2008 Dec; 217(3):717-27. PubMed ID: 18651620 [Abstract] [Full Text] [Related]
38. Regulation of the mGluR5, EAAT1 and GS expression by glucocorticoids in MG-63 osteoblast-like osteosarcoma cells. Kalariti N, Lembessis P, Papageorgiou E, Pissimissis N, Koutsilieris M. J Musculoskelet Neuronal Interact; 2007 Dec; 7(2):113-8. PubMed ID: 17627080 [Abstract] [Full Text] [Related]
39. Changes in protein tyrosine phosphatase type IVA member 1 and zinc finger protein 36 C3H type-like 1 expression demonstrate altered estrogen and progestin effect in medroxyprogesterone acetate-resistant and estrogen-independent breast cancer cell models. Pennanen PT, Sarvilinna NS, Purmonen SR, Ylikomi TJ. Steroids; 2009 Dec; 74(4-5):404-9. PubMed ID: 19146866 [Abstract] [Full Text] [Related]
40. IL-6 receptor expression and IL-6 effects change during osteoblast differentiation. Li Y, Bäckesjö CM, Haldosén LA, Lindgren U. Cytokine; 2008 Aug; 43(2):165-73. PubMed ID: 18555695 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]